time:
From January 8, 2023
plan:
Implementation of "Class B and B Control" for Novel Coronavirus Infection
background:
Virus mutation:
Experts at home and abroad generally believe that the general direction of virus mutation is lower pathogenicity, more tending to upper respiratory tract infection and shorter incubation period. The new coronavirus will exist in nature for a long time, and its pathogenicity is significantly lower than that in the early stage, causing diseases. It will gradually evolve into a common respiratory infectious disease.
Epidemic Situation:
The Omicron mutant strain has become the dominant strain in the world. Although the number of infected people is large, asymptomatic infections and mild cases account for more than 90%, and the severe and fatal rates are extremely low.
The basis of China's prevention and control:
China has currently received more than 3.4 billion doses of new coronavirus vaccines, and the vaccination rate of people over 3 years old has exceeded 90%. The research and development of specific antiviral drugs at home and abroad has made progress. Effective prescriptions; the vast number of medical and health personnel have accumulated rich experience in epidemic prevention and control and disposal, and their prevention and control capabilities have been significantly improved.
in conclusion:
my country already has the basic conditions to adjust the new type of coronavirus infection from "Class B and A control" to "Class B and B control".
arrange:
From January 8, 2023, "Class B and B control" will be implemented for new coronavirus infection.
According to the Law on the Prevention and Control of Infectious Diseases, isolation measures will no longer be implemented for people infected with the new coronavirus, and close contacts will no longer be identified;
High and low risk areas are no longer designated;
Implement hierarchical and classified admissions for patients infected with the new coronavirus and adjust medical insurance policies in a timely manner;
The detection strategy is adjusted to "willing to do all inspections";
Adjust the frequency and content of epidemic information releases.
According to the Frontier Health and Quarantine Law, no quarantine and infectious disease management measures will be taken for entry personnel and goods.
Main measures:
About the preparation of medical resources and classified treatment
Focus on preparing hospital beds and intensive care beds.
Further strengthen the establishment of fever clinics, and fever clinics in hospitals above the second level "should be set up and opened as much as possible."
Eligible square cabin hospitals will be upgraded to sub (quasi) designated hospitals.
Asymptomatic infections and mild cases without serious underlying diseases should take self-care at home.
Ordinary cases, elderly asymptomatic patients with serious underlying diseases but stable conditions, and mild cases will be treated in sub-designated hospitals.
Severe and critical cases with pneumonia as the main manifestation and cases requiring hemodialysis will be treated intensively in designated hospitals.
Severe and critical cases with basic diseases as the mainstay, and those with basic diseases beyond the medical treatment capabilities of primary medical and health institutions and sub-designated hospitals, will be treated in tertiary hospitals.
About nucleic acid testing
The detection strategy is adjusted to "willing to do all inspections"; nucleic acid screening for all staff will no longer be carried out.
Carry out antigen or nucleic acid testing for outpatients and emergency patients with fever and respiratory infection symptoms admitted to medical institutions, hospitalized patients with high risk of severe illness, and symptomatic medical staff.
During the epidemic period, regularly carry out antigen or nucleic acid testing for the staff and care recipients in elderly care institutions, social welfare institutions and other places where vulnerable groups are concentrated.
For community residents aged 65 and above, long-term hemodialysis patients, severe diabetes patients and other community residents at high risk of serious illness, and infants and young children under 3 years old, if they have symptoms such as fever, they should promptly guide antigen detection, or go to the convenient nucleic acid set up in the community Nucleic acid detection at the detection point.
Foreign personnel entering places where vulnerable groups gather, etc., check the negative nucleic acid test certificate within 48 hours and carry out antigen testing on the spot.
Keep enough convenient nucleic acid testing points in the community to ensure residents' "willing to test all tests" needs.
Ensure sufficient supply of antigen detection reagents in retail pharmacies, drug online sales e-commerce, etc.
About Epidemic Surveillance
Continue to dynamically track the mutation of viruses at home and abroad, and evaluate changes in characteristics such as virus transmission, pathogenicity, and immune escape capabilities.
Monitor the infection level of the community population, monitor the outbreak of the epidemic in key institutions, dynamically grasp the scale, scope, intensity and virus mutation of the epidemic, and judge the development trend of the epidemic.
Appropriate measures such as restricting gathering activities and the movement of people shall be adopted dynamically in accordance with the law to suppress the peak of the epidemic.
About vaccinations
Accelerate the improvement of vaccine booster immunization coverage, especially among the elderly.
People at high risk of infection, people aged 60 and over, people with serious underlying diseases, and people with low immunity can receive a second dose of booster immunization 6 months after completing the first dose of booster immunization Inoculation.
At present, all 13 vaccines approved for conditional marketing or emergency use can be used for the second dose of booster immunization, including 4 new vaccines for emergency use. Sequential booster immunization is recommended first, or contain Omicron strain or Vaccines with good cross-immunity to Omicron strains.
About immigration
According to the Frontier Health and Quarantine Law, no quarantine and infectious disease management measures will be taken for entry personnel and goods.
Persons coming to China should undergo a nucleic acid test 48 hours before departure. Those with a negative result can come to China without applying for a health code from our embassy or consulate abroad, and fill in the result in the customs health declaration card.
If positive, relevant personnel should come to China after turning negative.
Nucleic acid testing and centralized isolation for all staff after entry will be cancelled.
Those who have a normal health declaration and no abnormality in the routine quarantine at the customs port can be released to enter the society.
The number control measures for international passenger flights such as "five ones" and passenger load factor restrictions will be cancelled.
All airlines continue to do a good job in on-board epidemic prevention, and passengers must wear masks when boarding.
Further optimize arrangements for foreign nationals coming to China, such as resumption of work and production, business, study abroad, family visits, reunions, etc., and provide corresponding visa convenience.
According to the international epidemic situation and various service guarantee capabilities, the outbound travel of Chinese citizens will be resumed in an orderly manner.
(Chinanews WeChat public account)